Description
Biotechnology is now the science that defines the 21st century. This is book is a captivating memoir of biotech’s birth and maturation, by an accomplished scientist who became a successful biotech business executive. Tim Harris combines tales of scientific successes and failures with his personal story of ambition, challenge, and discovery. From the pioneering early days of gene cloning and monoclonal antibodies to current cutting-edge advances in cell therapy, gene editing, and personalized medicine, Harris provides a candid insider’s view of biotech’s remarkable evolution and its profound impact on health care. His story is rich in detail about the struggles and triumphs that played out in corporate laboratories and boardrooms and the often colorful personalities involved. Blending science, business, and ethics, Harris reflects on the complexities that come with rapid technological progress and the responsibilities of scientists in shaping the future.
“Unicorns is a new bible for the history of the biotechnology industry. In addition to a remarkable survey of the many biotech stories over the years, Harris also provides important perspective on all the needed elements to build great companies and deliver disruptive innovation to patients.”
John Maraganore, CEO and Principal, JMM Innovations, LLC; Founding CEO, Alnylam Pharmaceuticals
“Tim Harris was born to write this book—a fascinating one-man oral history of the biotechnology industry told by an industry insider with authority, verve, and wit. Highly recommended!”
Kevin Davies, author, Editing Humanity and Cracking the Genome
“Unicorns takes the reader on a fascinating journey from the beginnings of recombinant DNA technology to today's cutting-edge science and novel therapies. Few people have been part of this extraordinary expedition the way the author has and no one has shared his experiences in such a lucid and captivating style.”
Stelios Papadopoulos, ex-Chairman of Biogen and a former biotech investment banker with SG Cowen and PaineWebber
